Get it on Google Play

Rhelion unit ships psilocybin drug to University of Calgary PTSD trial

September 29, 2026 7:54 AM EDT Send to a Friend
Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX) (OTCQB: TRUFF) announced that its wholly owned subsidiary, Filament Health Corp., has ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login